Last updated 2026-07-24

TL;DR
You can use copper peptides under eyes, but formulation matters more here than anywhere else on the face. GHK-Cu at 0.01-0.1% shows collagen IV upregulation in ex-vivo skin [1], but the thin under-eye dermis (0.5 mm versus ~2 mm on the cheek) concentrates irritation risk. Liposomal delivery reduces irritation while preserving penetration, and avoiding ascorbic acid or retinoids in the same routine prevents copper destabilization.
Does GHK-Cu work on under-eye skin specifically?
GHK-Cu stimulates collagen IV production in both fibroblast cultures and ex-vivo human skin samples, with synergistic effects when combined with hyaluronic acid [1]. Collagen IV forms the basement membrane that anchors the epidermis to the dermis. Under-eye skin loses this structural anchor faster than other facial zones because the dermis is roughly half the thickness (0.5-0.8 mm periorbital versus 1.5-2.0 mm on the cheek). Nobody has run a split-face trial comparing under-eye to cheek response, but the tissue architecture suggests the area would respond if the peptide reaches the dermis. The catch is delivery. A 2025 study using capillary electrophoresis to track GHK-Cu inside liposomes found that encapsulation efficiency determines whether the peptide stays intact through the stratum corneum or degrades in the vehicle [2]. Free GHK-Cu in a simple cream base often oxidizes before penetration, turning the copper into an irritant rather than a collagen signal. The same study noted that copper release kinetics from liposomes can be tuned by adjusting lipid composition, but most cosmetic serums don't publish their encapsulation data. Under-eye application has one advantage: less sebum interference. GHK-Cu competes poorly with sebum lipids for dermal entry on the T-zone, but the periorbital area produces almost no sebum, so a well-formulated liposomal serum has a cleaner path to the dermis here than on the forehead. That doesn't mean you'll see faster results, just that formulation failure is the bottleneck, not the skin's capacity to respond.
What concentration is safe for the under-eye area?
Cosmetic formulations use 0.01% to 0.1% GHK-Cu for facial application [3], but the under-eye zone tolerates the lower end of that range better. A 2023 study testing GHK-Cu with hyaluronic acid used 0.05% GHK-Cu on ex-vivo skin and measured a 34% increase in collagen IV gene expression after 72 hours [1]. That's a middle-ground concentration. Going higher doesn't produce proportional gains because the tripeptide saturates its receptor binding sites, and excess copper ions have nowhere useful to go. Providers who dispense compounded formulations typically keep periorbital GHK-Cu at 0.01-0.03% when the patient has a history of contact dermatitis or rosacea. The thin dermis here means less buffering capacity for copper ions that dissociate from the complex. Free copper generates reactive oxygen species (the same mechanism that makes copper toxic to bacteria also makes it a contact irritant at high local concentrations). Liposomal encapsulation reduces this risk by controlling copper release, but even encapsulated forms can irritate if the total copper load is too high. If you're using a cosmetic serum, check the ingredient list for "copper tripeptide-1" or "GHK-Cu." If copper peptides appear in the first five ingredients, the concentration is likely above 0.1%, which is fine for the forearm but risky under the eyes. If it's listed in the bottom third, you're probably at 0.01-0.03%. No label obligation exists for exact percentages, so placement on the ingredient list is your only clue.
How does liposomal delivery change under-eye safety?
Liposomes are phospholipid vesicles that fuse with the stratum corneum, releasing their payload gradually as the skin's pH and lipid enzymes break down the vesicle membrane. A 2023 study on GHK-Cu liposomes for cosmetic application found that encapsulation increased dermal retention time by 40-60% compared to free peptide in a cream base [4]. That matters under the eyes because longer retention means you can use a lower total dose and still get sustained collagen signaling. The same study reported that liposomal GHK-Cu reduced irritation markers (IL-1α and TNF-α) in reconstructed human epidermis models compared to free GHK-Cu at the same concentration [4]. The mechanism is dose buffering: instead of dumping 0.05% copper peptide onto the dermis in one shot, the liposome releases it over 6-8 hours, keeping local copper concentrations below the irritation threshold while maintaining the biological signal. This is especially helpful under the eyes, where the lymphatic drainage is slower and excess copper lingers longer. Not all liposomes are equal. Multilamellar vesicles (MLVs) are cheaper to produce and common in mass-market serums, but they're large (1-5 microns) and don't penetrate well. Unilamellar vesicles (ULVs) are 100-200 nanometers and cross the stratum corneum more efficiently, but they cost more to manufacture, so you'll find them in provider-dispensed or premium formulations. A 2025 study specifically testing skin permeation of GHK-Cu in liposomes concluded that current analytical methods struggle to distinguish intact peptide from degraded fragments once the liposome crosses the epidermis, which means even high-quality formulations are delivering an unknown mix of active and inactive copper species [5]. If your under-eye serum is cheap and lists "liposomal copper peptide," assume MLVs and low penetration.
What are the contraindications for periorbital use?
You should not use GHK-Cu under your eyes if you have active periorbital dermatitis, including eczema, seborrheic dermatitis, or contact dermatitis from other products. Copper ions are pro-oxidant in inflamed tissue, and applying GHK-Cu to compromised skin can worsen redness and scaling. A 2020 study on GHK-Cu in bleomycin-induced pulmonary fibrosis (a lung model, but relevant for oxidative stress) found that GHK-Cu reduced oxidative markers in healthy tissue but had no protective effect in already-inflamed tissue [6]. The peptide works best when the baseline oxidative state is manageable, not when the tissue is already overwhelmed. Wilson's disease and other copper-overload conditions are absolute contraindications for any copper peptide use, topical or injectable. Your liver can't clear excess copper, and even small amounts absorbed through the skin add to the systemic burden. This is rare (Wilson's affects roughly 1 in 30,000 people), but if you've been told to avoid dietary copper, you need to avoid topical copper too. Pregnancy and breastfeeding have no specific safety data for topical GHK-Cu. No teratology studies exist, and the peptide is too new for post-market surveillance to capture pregnancy outcomes. The conservative call is to avoid it. The liberal call is that topical absorption is low enough that systemic copper levels won't budge, but nobody has measured that. If you're compounding through a 503A pharmacy (see sourcing), your provider may decline to prescribe it during pregnancy, and that's a reasonable boundary. Do not combine GHK-Cu with vitamin C (ascorbic acid) or copper-chelating ingredients like EDTA in the same routine. Ascorbic acid reduces Cu²⁺ to Cu⁺, which destabilizes the GHK-Cu complex and generates free copper ions that irritate. If you're using a vitamin C serum, apply it in the morning and GHK-Cu at night, or use them on alternating days. Some cosmetic chemists combine them intentionally to generate a mild irritant response (the theory is that low-grade inflammation stimulates collagen turnover), but that's a bad idea under the eyes where irritation shows immediately as puffiness and redness.
Does injectable GHK-Cu work for under-eye bags or dark circles?
Injectable GHK-Cu has no published evidence for periorbital use, and I would not use it there. The injectable literature focuses on wound healing, ACL reconstruction, and systemic inflammation [7][8][9], not cosmetic facial applications. Injecting near the orbital rim risks three problems: first, the peptide is hyperosmolar and will draw fluid into the injection site, temporarily worsening puffiness. Second, the under-eye area has little subcutaneous fat, so any injection volume sits superficially and creates visible lumps. Third, copper has lipolytic effects (it activates enzymes that break down triglycerides), and periorbital fat loss is permanent. You do not want to dissolve the orbital fat pad with repeated injections. A 2015 rat study on ACL reconstruction injected GHK-Cu directly into the patellar tendon and found improved collagen alignment at 4 weeks but no difference at 12 weeks [8]. That tells you the peptide's effects are transient, not cumulative, when delivered as a bolus injection. For cosmetic under-eye improvement, you need sustained collagen signaling, which means repeated injections. Repeated periorbital injections carry a real risk of fat atrophy, and once the fat pad is gone, the only fix is filler or fat grafting. Some practices offer subdermal GHK-Cu injections for facial rejuvenation, typically 0.5-1.0 mg per session, placed in the mid-cheek or jawline. That's off-label, not FDA-approved, and compounded under 503A or 503B rules. If you're considering it, ask the provider whether they've treated the periorbital zone before and what their complication rate is. If they say they've never had a problem, find a different provider. Every injectable has complications, and a zero-complication claim means either very few patients or very poor follow-up.
How long does it take to see results under the eyes?
Topical GHK-Cu takes 8-12 weeks to produce visible collagen effects, and under-eye changes lag behind the rest of the face because the dermis is thinner and the tissue remodeling rate is slower. A 2023 study measuring collagen IV upregulation in ex-vivo skin saw gene expression changes at 72 hours, but gene expression is upstream from actual collagen deposition [1]. The collagen has to be synthesized, secreted, cross-linked, and organized into functional fibrils, and that process takes weeks, not days. If you're using GHK-Cu for under-eye wrinkles (crow's feet, fine lines on the lower lid), expect incremental improvement at 8 weeks and plateau by 16 weeks. If you're using it for under-eye bags (fat herniation) or dark circles (vascular or pigmentary), expect no improvement, because GHK-Cu doesn't shrink fat pads or lighten melanin. It builds collagen, and collagen can slightly tighten lax skin, but it won't fix anatomical volume or pigment issues. Some users report faster "plumping" in the first few weeks. That's probably hyaluronic acid in the serum formulation drawing water into the dermis, not collagen synthesis. It's a real effect, just not the peptide's direct action. If your serum contains both GHK-Cu and hyaluronic acid (many do), the short-term hydration effect makes the skin look better while you wait for the collagen to build. That's fine, just don't mistake it for peptide-driven collagen remodeling.
What's the best application technique for under-eye GHK-Cu?
Apply GHK-Cu serum to clean, dry skin. "Dry" means you've patted your face after cleansing and waited 30-60 seconds for residual water to evaporate. Applying peptides to damp skin increases penetration but also increases irritation risk, and under the eyes, irritation outweighs any penetration benefit. Use one to two drops total for both eyes. If you're using a dropper bottle, that's roughly 0.05 mL per eye. Pat the serum onto the orbital bone (the bony rim under your eye), not on the movable eyelid skin. The product will migrate slightly during the night, and you want the migration path to be inward (toward the eye socket) rather than upward (onto the thin lid skin where it's more likely to irritate). Don't rub. Rubbing generates friction heat, which can destabilize the copper complex, and it also pushes product into the lash line where it can cause irritation or styes. Patting with your ring finger (the weakest finger, so you apply the least pressure) is the standard recommendation. Let the serum absorb for 3-5 minutes before applying anything else. If you're layering other products, put GHK-Cu on first, because it needs direct dermal contact. If you put an occlusive (like squalane or petrolatum) on first, the peptide can't penetrate. Frequency: start with once every other night for two weeks, then move to nightly if you have no irritation. Some people tolerate twice-daily application (morning and night), but morning application under makeup can cause pilling (the serum balls up when you apply foundation), and daytime copper exposure to UV generates more reactive oxygen species than nighttime use. If you're going to pick one application time, pick bedtime.
Can you combine GHK-Cu with retinoids or other actives under the eyes?
You can combine GHK-Cu with retinoids (tretinoin, adapalene, retinol), but not in the same application session, and the under-eye zone is the worst place to test that combination. Retinoids and copper peptides both stimulate collagen synthesis through different pathways (retinoids work via retinoic acid receptors, GHK-Cu works via TGF-β signaling [10]), so in theory they're additive. In practice, both are irritants, and applying both under the eyes in the same 24-hour window often causes redness, peeling, or contact dermatitis. If you want to use both, alternate nights: GHK-Cu on Monday, Wednesday, Friday; retinoid on Tuesday, Thursday, Saturday; nothing on Sunday. That gives each active a clear metabolic window and lets the skin recover. Some dermatologists recommend using retinoids on the crow's feet and outer orbital area (where the skin is thicker) and GHK-Cu on the lower lid (where retinoid irritation is more common), but that's a clinical judgment call based on your skin's tolerance. Never layer GHK-Cu and vitamin C (ascorbic acid) in the same routine under your eyes. Ascorbic acid destabilizes the copper complex, as noted earlier. If you're using a vitamin C serum for pigmentation, apply it in the morning after cleansing, let it absorb, then apply sunscreen. Use GHK-Cu at night. The two products will never meet on your skin, and that's the goal. Peptide combinations (like pairing GHK-Cu with Matrixyl or Argireline) are generally safe because most peptides have distinct mechanisms and don't interfere with each other. A 2023 study on GHK-Cu with hyaluronic acid showed synergistic collagen IV upregulation, which suggests that pairing GHK-Cu with other extracellular matrix components works better than using it alone [1]. If your serum contains multiple peptides, that's fine, as long as the total concentration of each stays within the safe range.
What about allergic reactions or copper sensitivity?
True copper allergy (Type IV delayed hypersensitivity to copper ions) is rare, estimated at under 1% of the population, but contact dermatitis from copper-containing products is more common because the formulation, more than the copper, drives the reaction. A 2020 study on ternary copper complexes (GHK plus another ligand) found that the choice of counter-ligand changed the complex's redox potential and its tendency to release free copper [11]. Cosmetic serums rarely disclose the full copper speciation, so you don't know whether you're getting GHK-Cu with a stabilizing ligand or GHK-Cu that sheds copper easily. If you've had a reaction to copper jewelry (green discoloration or itching where the jewelry touched your skin), that's copper corrosion, not allergy. Copper corrodes in sweat and forms copper salts, which are irritants. But it does mean you're exposed to copper ions and your skin reacts, so test any GHK-Cu product on your inner forearm for 48 hours before using it on your face. If you see redness, swelling, or itching, stop. If you see nothing, proceed cautiously to the face. Patch testing is the standard way to diagnose copper allergy. A dermatologist applies copper sulfate (not GHK-Cu, but pure copper salt) to your back under an occlusive patch and reads the reaction at 48 and 96 hours. If you react to the patch test, you should avoid all copper-containing skincare. If you don't react to the patch test but do react to a GHK-Cu serum, the problem is the formulation (preservatives, solvents, or fragrance), not the copper itself.
Where can you get high-quality GHK-Cu for under-eye use?
You have three routes: cosmetic serums, provider-compounded formulations, and research-grade peptide suppliers. Cosmetic serums are the easiest path and work if you want a low-concentration liposomal product for general facial use including under the eyes. Look for products that list "copper peptide" or "GHK-Cu" with liposomal delivery and no added vitamin C or strong acids. Expect to pay $40-$80 for a 30 mL bottle. Most don't publish third-party assays, so you're trusting the brand's internal quality control. Provider-compounded formulations go through a 503A or 503B pharmacy (see sourcing). GHK-Cu is not on the FDA's 503A bulk substance list [12], which means a compounding pharmacy can't make it for you unless your doctor submits a nomination to the FDA and the FDA grants it, or the pharmacy uses it under 503B rules (which allow broader discretion but require more manufacturing oversight). Most compounded GHK-Cu is 503B, dispensed by a provider who orders it from an outsourcing facility. These formulations are typically 0.01-0.03% GHK-Cu in a lipid or liposomal base, and they come with a certificate of analysis (CoA) showing peptide purity and copper content. Cost is $100-$200 for a 15-30 mL dispenser, and you'll need a provider consultation to get it. Research-grade GHK-Cu from peptide synthesis companies (not named here because this is a clinical article, not a sourcing guide) is sold as powder with a CoA but no safety or sterility testing for human use. Reconstituting and formulating it yourself is legal but risky: you can over-concentrate it, contaminate it, or choose a vehicle that doesn't stabilize the copper complex. If you go this route, read the CoA carefully. Purity should be ≥95% by HPLC, and copper content should match the stoichiometric ratio (one copper atom per tripeptide molecule, so roughly 10% of the total mass should be copper). If the copper content is off, the peptide is either degraded or mis-synthesized. For under-eye use specifically, I'd start with a provider-compounded liposomal formulation at 0.01-0.02% rather than a cosmetic serum, because the provider can adjust the concentration based on your tolerance and the CoA gives you confidence in what you're applying. If you react well after three months, a cosmetic serum is a cheaper maintenance option.
Frequently asked questions
Can GHK-Cu cause milia under the eyes?
No direct evidence links GHK-Cu to milia, but heavy occlusive serums (which many copper peptide products are) can trap keratin under the skin and form milia. If your GHK-Cu serum contains petrolatum, dimethicone, or shea butter high in the ingredient list, reduce frequency or switch to a lighter liposomal formula. Milia are mechanical, not chemical.
Does GHK-Cu make under-eye bags worse?
Topical GHK-Cu won't worsen fat herniation (the anatomical cause of most under-eye bags), but if the serum is hypertonic or causes low-grade inflammation, you can get temporary fluid retention that looks like worsening bags. Liposomal formulations reduce this risk. Injectable GHK-Cu near the orbit is more likely to cause transient puffiness and should be avoided.
Can you use GHK-Cu on eyelids?
You can, but the movable eyelid skin is thinner and more permeable than the under-eye area, so irritation risk is higher. If you're treating the upper lid, use half the concentration you'd use under the eyes (0.005-0.01%), apply to the bony orbital rim rather than the lid crease, and expect migration. Avoid the lash line entirely to prevent styes.
How does GHK-Cu compare to peptides like Matrixyl for under-eye wrinkles?
Matrixyl (palmitoyl pentapeptide-4) stimulates collagen I and III through a different receptor pathway than GHK-Cu, which targets collagen IV and basement membrane. Both have evidence for wrinkle reduction on facial skin, but GHK-Cu has more published data on wound healing and inflammation. Some formulations combine them. Neither has a head-to-head under-eye trial, so we don't know which performs better in that zone.
Will GHK-Cu lighten dark circles?
No. Dark circles are either vascular (blood pooling visible through thin skin), pigmentary (post-inflammatory hyperpigmentation or genetic melanin), or structural (shadowing from a deep tear trough). GHK-Cu builds collagen; it doesn't constrict vessels, lighten melanin, or fill volume. It might slightly improve skin thickness, which can reduce vascular show-through, but that's a marginal effect.
Can you use GHK-Cu with retinol under the eyes?
Yes, but alternate nights. Both are collagen stimulants and both can irritate. If you apply them on the same night, the combined irritation often causes redness and peeling under the eyes, where the skin has little buffering capacity. GHK-Cu Monday/Wednesday/Friday, retinol Tuesday/Thursday/Saturday is a safe schedule.
Is GHK-Cu safe for use with contact lenses?
Topical periorbital GHK-Cu shouldn't interact with contact lenses if you apply it to the orbital bone (not the eyelid margin or lash line) and let it absorb before inserting lenses. If product migrates into the tear film, copper ions can bind to lens proteins and cause discoloration or discomfort. Remove lenses before application, wait 10-15 minutes, then reinsert if needed.
Does GHK-Cu help with crow's feet specifically?
Crow's feet (lateral canthal lines) respond to collagen-building actives if the lines are dynamic or superficial. GHK-Cu's collagen IV effects in ex-vivo skin suggest it can improve dermal thickness and elasticity over 12-16 weeks [1], which may soften shallow crow's feet. Deep etched lines need neurotoxin (Botox) or filler. GHK-Cu is maintenance, not correction.
Can you use GHK-Cu after Botox or filler in the under-eye area?
Yes, but wait 48 hours after injection to avoid introducing another variable if you have swelling or bruising. GHK-Cu doesn't interact pharmacologically with hyaluronic acid fillers or botulinum toxin. If you had tear trough filler placed, applying GHK-Cu on top won't dissolve or migrate the filler, but it also won't extend the filler's duration.
How should you store GHK-Cu serum to keep it effective for under-eye use?
Store GHK-Cu in a cool, dark place. Copper peptides oxidize with heat, light, and air exposure, turning from blue-green to brown and losing activity. If your serum changes color or develops an off smell, discard it. Refrigeration extends shelf life (expect 6-9 months refrigerated versus 3-4 months at room temperature), but don't freeze it; freezing ruptures liposomes. Use an airtight pump bottle, not a dropper, to minimize air exposure.
Will GHK-Cu interfere with under-eye concealer or makeup?
Liposomal GHK-Cu serums are usually silicone-based or lipid-based and can pill (ball up) under silicone primers or heavy foundations. Let the serum absorb completely (3-5 minutes) before applying makeup. If pilling persists, switch to a water-based GHK-Cu formula or apply it only at night.
Does GHK-Cu penetrate better under the eyes than on other facial areas?
Penetration is similar or slightly better under the eyes because there's no sebum barrier, but irritation sensitivity is higher because the dermis is thin. A product that works on your cheeks can still irritate under your eyes at the same concentration. Start with lower-concentration formulations (0.01-0.02%) for periorbital use even if you tolerate 0.05-0.1% elsewhere.
Can you use GHK-Cu under the eyes during the day or just at night?
You can use it during the day, but nighttime is better. UV exposure generates reactive oxygen species from copper ions, which increases oxidative stress rather than reducing it. If you apply GHK-Cu in the morning, follow immediately with a broad-spectrum sunscreen (SPF 30+). Nighttime use avoids this issue and gives the peptide uninterrupted time to work without UV interference.
How long does a bottle of GHK-Cu last for under-eye use only?
A 30 mL bottle used only under the eyes (1-2 drops per eye per night) lasts roughly 4-6 months. If you're applying it to the full face, expect 1-2 months. Most serums list 6-12 month post-opening stability, but oxidation accelerates once the bottle is opened, so using it within 3-4 months ensures you're getting active peptide.
Sources
- Journal of Cosmetic Dermatology, 2023: GHK-Cu with hyaluronic acid increased collagen IV gene expression by 34% in ex-vivo skin at 72 hours
- Electrophoresis, 2024: Capillary electrophoresis tracking found encapsulation efficiency determines GHK-Cu stability and dermal penetration
- BioImpacts, 2025: Topical GHK-Cu formulations for anti-wrinkle use typically range from 0.01% to 0.1%
- Pharmaceutics, 2023: Liposomal GHK-Cu increased dermal retention by 40-60% and reduced IL-1α and TNF-α in reconstructed epidermis models versus free peptide
- Molecules, 2025: Current analytical methods cannot distinguish intact GHK-Cu from degraded fragments after liposomal penetration of the epidermis
- Life Sciences, 2020: GHK-Cu reduced oxidative markers in healthy tissue but showed no protective effect in already-inflamed tissue in a bleomycin fibrosis model
- Journal of the American Academy of Orthopaedic Surgeons, 2026: Injectable peptide therapy applications in orthopaedics focus on wound healing and tissue repair, not cosmetic facial use
- Journal of Orthopaedic Research, 2015: GHK-Cu injected into rat patellar tendon improved collagen alignment at 4 weeks but showed no difference at 12 weeks
- Wound Repair and Regeneration, 2017: GHK-Cu liposomes accelerated scald wound healing in mice by promoting cell proliferation and angiogenesis
- International Journal of Molecular Sciences, 2018: GHK-Cu activates gene expression related to collagen synthesis and tissue remodeling through TGF-β signaling pathways
- International Journal of Molecular Sciences, 2020: Ternary copper complex with GHK and cis-urocanic acid showed different redox potential and copper release profile than GHK-Cu alone
- FDA Bulk Drug Substances for 503A Compounding: GHK-Cu is not on the FDA's 503A bulk substance list, requiring nomination for 503A compounding or use under 503B rules